The Scriptura Therapeutics Library is a structured reference for the compounds longevity prescribers actually use in practice. Each entry is written for the treating clinician, not for a search engine.
Every profile includes:
- Mechanism, in plain English
- Evidence class and the strongest studies that support current practice
- Common indications and off-label patterns in longevity medicine
- Typical dosing, route, and cycle length
- Contraindications and drug interaction watch list
- The biomarkers to check before, during, and after a cycle
- Regulatory posture, including FDA guidance, 503A and 503B considerations, and current state pharmacy notes
The library covers the compounds that matter most to longevity practice today. BPC-157. TB-500. GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide. Growth hormone secretagogues including CJC-1295, ipamorelin, sermorelin, and tesamorelin. Thymosin peptides. KPV. LL-37. Epithalon. DSIP. And the list is growing as new evidence lands.
When new evidence lands (see the Clinical Evidence pillar), the therapeutic profile updates and the prescriber sees the delta, not another PDF.
Written by the Scriptura Health clinical team. For clinician review only. Not medical advice. Every dose and cycle is a clinical judgment for the treating prescriber.